This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eichhorst, S. T.
Right arrow Articles by Krammer, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eichhorst, S. T.
Right arrow Articles by Krammer, P. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 2000, p. 7826-7837, Vol. 20, No. 20
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

A Novel AP-1 Element in the CD95 Ligand Promoter Is Required for Induction of Apoptosis in Hepatocellular Carcinoma Cells upon Treatment with Anticancer Drugs

Sören T. Eichhorst,1 Martina Müller,2 Min Li-Weber,1 Henning Schulze-Bergkamen,2 Peter Angel,3 and Peter H. Krammer1,*

Tumor Immunology Program1 and Division of Signal Transduction German Cancer Research Center (DKFZ),3 69120 Heidelberg, and Department of Internal Medicine IV Hepatology and Gastroenterology, University Hospital, 69115 Heidelberg,2 Germany

Received 23 February 2000/Returned for modification 13 April 2000/Accepted 28 July 2000

The CD95 (also called APO-1 or Fas) system plays a major role in the induction of apoptosis in lymphoid and nonlymphoid tissues in response to a variety of extracellular signals, including chemotherapeutic drugs. Here we report that the CD95 ligand (CD95L) is upregulated in hepatoma cells upon treatment with antineoplastic drugs. Upregulation by different chemotherapeutic drugs is functionally relevant for drug-induced apoptosis and is mediated by transcriptional mechanisms. The MEKK1/JNKK pathway and a novel AP-1 element in the CD95L promoter downstream of the TATA box are required for CD95L upregulation. Thus, understanding the mechanisms of CD95-mediated apoptosis through CD95L upregulation upon treatment of hepatocellular carcinomas with chemotherapeutic drugs may contribute to the improvement of anticancer chemotherapy.

* Corresponding author. Mailing address: Division of Immunogenetics (G0300), German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. Phone: 49-6221-423718. Fax: 49-6221-411715. E-mail: P.Krammer{at}dkfz.de.

Molecular and Cellular Biology, October 2000, p. 7826-7837, Vol. 20, No. 20
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Lee, Y. C., Chuang, C.-Y., Lee, P.-K., Lee, J.-S., Harper, R. W., Buckpitt, A. B., Wu, R., Oslund, K. (2008). TRX-ASK1-JNK signaling regulation of cell density-dependent cytotoxicity in cigarette smoke-exposed human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L921-L931 [Abstract] [Full Text]  
  • Baumann, S., Fas, S. C., Giaisi, M., Muller, W. W., Merling, A., Gulow, K., Edler, L., Krammer, P. H., Li-Weber, M. (2008). Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLC{gamma}1- and Ca2+-dependent apoptosis. Blood 111: 2354-2363 [Abstract] [Full Text]  
  • DeMorrow, S., Francis, H., Gaudio, E., Ueno, Y., Venter, J., Onori, P., Franchitto, A., Vaculin, B., Vaculin, S., Alpini, G. (2008). Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G506-G519 [Abstract] [Full Text]  
  • Morgan, R., Pirard, P. M., Shears, L., Sohal, J., Pettengell, R., Pandha, H. S. (2007). Antagonism of HOX/PBX Dimer Formation Blocks the In vivo Proliferation of Melanoma. Cancer Res. 67: 5806-5813 [Abstract] [Full Text]  
  • Ansorena, E., Berasain, C., Zabalza, M. J. L., Avila, M. A., Garcia-Trevijano, E. R., Iraburu, M. J. (2006). Differential regulation of the JNK/AP-1 pathway by S-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1186-G1193 [Abstract] [Full Text]  
  • Contini, P., Ghio, M., Merlo, A., Poggi, A., Indiveri, F., Puppo, F. (2005). Apoptosis of Antigen-Specific T Lymphocytes upon the Engagement of CD8 by Soluble HLA Class I Molecules Is Fas Ligand/Fas Mediated: Evidence for the Involvement of p56lck, Calcium Calmodulin Kinase II, and Calcium-Independent Protein Kinase C Signaling Pathways and for NF-{kappa}B and NF-AT Nuclear Translocation. J. Immunol. 175: 7244-7254 [Abstract] [Full Text]  
  • Kuntzen, C., Sonuc, N., De Toni, E. N., Opelz, C., Mucha, S. R., Gerbes, A. L., Eichhorst, S. T. (2005). Inhibition of c-Jun-N-terminal-Kinase Sensitizes Tumor Cells to CD95-Induced Apoptosis and Induces G2/M Cell Cycle Arrest. Cancer Res. 65: 6780-6788 [Abstract] [Full Text]  
  • Xia, S., Rosen, E. M., Laterra, J. (2005). Sensitization of Glioma Cells to Fas-Dependent Apoptosis by Chemotherapy-Induced Oxidative Stress. Cancer Res. 65: 5248-5255 [Abstract] [Full Text]  
  • Gulow, K., Kaminski, M., Darvas, K., Suss, D., Li-Weber, M., Krammer, P. H. (2005). HIV-1 Trans-Activator of Transcription Substitutes for Oxidative Signaling in Activation-Induced T Cell Death. J. Immunol. 174: 5249-5260 [Abstract] [Full Text]  
  • Cippitelli, M., Fionda, C., Di Bona, D., Piccoli, M., Frati, L., Santoni, A. (2005). Hyperthermia Enhances CD95-Ligand Gene Expression in T Lymphocytes. J. Immunol. 174: 223-232 [Abstract] [Full Text]  
  • Catley, L., Tai, Y.-T., Shringarpure, R., Burger, R., Son, M. T., Podar, K., Tassone, P., Chauhan, D., Hideshima, T., Denis, L., Richardson, P., Munshi, N. C., Anderson, K. C. (2004). Proteasomal Degradation of Topoisomerase I Is Preceded by c-Jun NH2-Terminal Kinase Activation, Fas Up-Regulation, and Poly(ADP-Ribose) Polymerase Cleavage in SN38-Mediated Cytotoxicity against Multiple Myeloma. Cancer Res. 64: 8746-8753 [Abstract] [Full Text]  
  • Hess, J., Angel, P., Schorpp-Kistner, M. (2004). AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117: 5965-5973 [Abstract] [Full Text]  
  • Toh, W. H., Siddique, M. M., Boominathan, L., Lin, K. W., Sabapathy, K. (2004). c-Jun Regulates the Stability and Activity of the p53 Homologue, p73. J. Biol. Chem. 279: 44713-44722 [Abstract] [Full Text]  
  • Kurokawa, Y., Matoba, R., Nagano, H., Sakon, M., Takemasa, I., Nakamori, S., Dono, K., Umeshita, K., Ueno, N., Ishii, S., Kato, K., Monden, M. (2004). Molecular Prediction of Response to 5-Fluorouracil and Interferon-{alpha} Combination Chemotherapy in Advanced Hepatocellular Carcinoma. Clin. Cancer Res. 10: 6029-6038 [Abstract] [Full Text]  
  • Shrivastava, P., Pantano, C., Watkin, R., McElhinney, B., Guala, A., Poynter, M. L., Persinger, R. L., Budd, R., Janssen-Heininger, Y. (2004). Reactive Nitrogen Species-Induced Cell Death Requires Fas-Dependent Activation of c-Jun N-Terminal Kinase. Mol. Cell. Biol. 24: 6763-6772 [Abstract] [Full Text]  
  • Duan, X., Zhou, Z., Jia, S.-F., Colvin, M., Lafleur, E. A., Kleinerman, E. S. (2004). Interleukin-12 Enhances the Sensitivity of Human Osteosarcoma Cells to 4-Hydroperoxycyclophosphamide by a Mechanism Involving the Fas/Fas-Ligand Pathway. Clin. Cancer Res. 10: 777-783 [Abstract] [Full Text]  
  • Waxman, D. J., Schwartz, P. S. (2003). Harnessing Apoptosis for Improved Anticancer Gene Therapy. Cancer Res. 63: 8563-8572 [Abstract] [Full Text]  
  • Geller, J., Petak, I., Szucs, K. S., Nagy, K., Tillman, D. M., Houghton, J. A. (2003). Interferon-{gamma}-Induced Sensitization of Colon Carcinomas to ZD9331 Targets Caspases, Downstream of Fas, Independent of Mitochondrial Signaling and the Inhibitor of Apoptosis Survivin. Clin. Cancer Res. 9: 6504-6515 [Abstract] [Full Text]  
  • Chung, F.-L., Schwartz, J., Herzog, C. R., Yang, Y.-M. (2003). Tea and Cancer Prevention: Studies in Animals and Humans. J. Nutr. 133: 3268S-3274 [Abstract] [Full Text]  
  • Wendling, J., Marchand, A., Mauviel, A., Verrecchia, F. (2003). 5-Fluorouracil Blocks Transforming Growth Factor-{beta}-Induced {alpha}2 Type I Collagen Gene (COL1A2) Expression in Human Fibroblasts via c-Jun NH2-Terminal Kinase/Activator Protein-1 Activation. Mol. Pharmacol. 64: 707-713 [Abstract] [Full Text]  
  • Rodriguez, C. O. Jr, Stellrecht, C. M., Gandhi, V. (2003). Mechanisms for T-cell selective cytotoxicity of arabinosylguanine. Blood 102: 1842-1848 [Abstract] [Full Text]  
  • Mansouri, A., Ridgway, L. D., Korapati, A. L., Zhang, Q., Tian, L., Wang, Y., Siddik, Z. H., Mills, G. B., Claret, F. X. (2003). Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells. J. Biol. Chem. 278: 19245-19256 [Abstract] [Full Text]  
  • Cippitelli, M., Fionda, C., Di Bona, D., Lupo, A., Piccoli, M., Frati, L., Santoni, A. (2003). The Cyclopentenone-Type Prostaglandin 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanisms. J. Immunol. 170: 4578-4592 [Abstract] [Full Text]  
  • Cuadrado, A., Garcia-Fernandez, L. F., Gonzalez, L., Suarez, Y., Losada, A., Alcaide, V., Martinez, T., Fernandez-Sousa, J. M., Sanchez-Puelles, J. M., Munoz, A. (2003). AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK. J. Biol. Chem. 278: 241-250 [Abstract] [Full Text]  
  • Mor, G., Sapi, E., Abrahams, V. M., Rutherford, T., Song, J., Hao, X.-Y., Muzaffar, S., Kohen, F. (2003). Interaction of the Estrogen Receptors with the Fas Ligand Promoter in Human Monocytes. J. Immunol. 170: 114-122 [Abstract] [Full Text]  
  • Janssen-Heininger, Y. M. W., Persinger, R. L., Korn, S. H., Pantano, C., McElhinney, B., Reynaert, N. L., Langen, R. C. J., Ckless, K., Shrivastava, P., Poynter, M. E. (2002). Reactive Nitrogen Species and Cell Signaling: Implications for Death or Survival of Lung Epithelium. Am. J. Respir. Crit. Care Med. 166: S9-16 [Abstract] [Full Text]  
  • Schwartzberg, L. S., Petak, I., Stewart, C., Turner, P. K., Ashley, J., Tillman, D. M., Douglas, L., Tan, M., Billups, C., Mihalik, R., Weir, A., Tauer, K., Shope, S., Houghton, J. A. (2002). Modulation of the Fas Signaling Pathway by IFN-{gamma} in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-{gamma}, 5-Fluorouracil, and Leucovorin. Clin. Cancer Res. 8: 2488-2498 [Abstract] [Full Text]  
  • Meng, X. W., Heldebrant, M. P., Kaufmann, S. H. (2002). Phorbol 12-myristate 13-Acetate Inhibits Death Receptor-mediated Apoptosis in Jurkat Cells by Disrupting Recruitment of Fas-associated Polypeptide with Death Domain. J. Biol. Chem. 277: 3776-3783 [Abstract] [Full Text]  
  • Devadas, S., Zaritskaya, L., Rhee, S. G., Oberley, L., Williams, M. S. (2002). Discrete Generation of Superoxide and Hydrogen Peroxide by T Cell Receptor Stimulation: Selective Regulation of Mitogen-Activated Protein Kinase Activation and Fas Ligand Expression. JEM 195: 59-70 [Abstract] [Full Text]  
  • Ghose, A., Fleming, J., El-Bayoumy, K., Harrison, P. R. (2001). Enhanced Sensitivity of Human Oral Carcinomas to Induction of Apoptosis by Selenium Compounds: Involvement of Mitogen-activated Protein Kinase and Fas Pathways. Cancer Res. 61: 7479-7487 [Abstract] [Full Text]  
  • Eichhorst, S. T., Müerköster, S., Weigand, M. A., Krammer, P. H. (2001). The Chemotherapeutic Drug 5-Fluorouracil Induces Apoptosis in Mouse Thymocytes in Vivo via Activation of the CD95(APO-1/Fas) System. Cancer Res. 61: 243-248 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»